Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status

Lancet

Volumn 359, Issue 9316, 2002, Pages 1471-1477

  Haffty, Bruce G ^a   Harrold, Elizabeth ^a   Khan, Atif J ^a   Pathare, Pradip ^a   Smith, Tanya E ^a   Turner, Bruce C ^a   Glazer, Peter M ^a   Ward, Barbara ^a   Carter, Daryl ^a   Matloff, Ellen ^a   Bale, Allen E ^a   Alvarez Franco, Mayra ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

ADULT; AGE; ARTICLE; BREAST CARCINOMA; CANCER CLASSIFICATION; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FOLLOW UP; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MASTECTOMY; OUTCOMES RESEARCH; OVARIECTOMY; PARTIAL MASTECTOMY; PATHOLOGY; PRIORITY JOURNAL; RISK FACTOR; WILD TYPE;

EID: 0037181697     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)08434-9     Document Type: Article

References (31)

1. Factors influencing the effect of age on prognosis in breast cancer: Population based study
2. Breast carcinomas occurring in young women are different
3. Age as a prognostic factor in premenopausal breast carcinoma
4. Germ-line mutations in BRCA1 in Jewish and non-Jewish women with early-onset breast cancer
5. BRCA-associated breast cancer in young women
6. Linkage of early-onset familial breast cancer to chromosome 17q21
7. A strong candidate for the breast and ovarian cancer suspectibility gene BRCA1
8. Identification of the breast cancer susceptibility gene BRCA2
9. Germline BRCA1 185delAG mutations in Jewish women with breast cancer
10. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer
11. BRCA1 and BRCA2: From molecular genetics to clinical medicine
12. Risks of cancer in BRCA1-mutation carriers
13. The breast cancer information core:database design, structure and scope
14. Survival and tumour characteristics of breast cancer patients with germline mutations of BRCA1
15. Hereditary breast cancer: Pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage
16. Survival of BRCA1 breast and ovarian cancer patients: A population-based study from southern Sweden
17. Breast carcinomas arising in carriers of mutations in BRCA1 or BRCA2: Are they prognostically different?
18. Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast
19. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer
20. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 Trial
21. Effect of radiotherapy following breast-conserving treatment in women with breast cancer and germline BRCA1/2 mutations
22. BRCA1/BRCA2 germline mutations in locally recurrent breast cancer patients after lumpectomy and radiation therapy: Implications for breast conserving management in patients with BRCA1/BRCA2 mutations
23. Breast conservation therapy (BCT) for invasive breast cancer in Ashkenazi women with BRCA gene founder mutations
24. Local recurrence following lumpectomy and irradiation in familial and hereditary vs sporadic breast cancer patients
25. Decision analysis: Effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations
26. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer
27. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking BRCA2
28. BRCA1/2 germline mutations: A marker for radioresistance or radiosensitivity?
29. Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers
30. Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: A case-control study